PMID: 6103791Mar 1, 1980Paper

Studies in the rabbit on 3-methyltriazolophthalazine, an acetylated metabolite of hydralazine. Evidence for an alternative route of formation

Drug Metabolism and Disposition : the Biological Fate of Chemicals
T TalsethJ L McNay

Abstract

The formation and disposition of 3-methyltriazolophthalazine (MTP), an acetylated metabolite of hydralazine (H) was studied in rabbits. Following its iv administration MTP was rapidly and almost completely metabolized. The major metabolite in plasma and urine was found to be a hitherto unrecognized glucuronide conjugate, most likely of the carboxylic acid analogue of MTP. The hydralazine-pyruvic acid hydrazone (HPH), which is a major plasma metabolite of H, was recognized as a more potent source for MPT in vivo than was parent H. MTP was also formed in significant amounts in vitro following incubation of HPH in phosphate buffer. We conclude that MTP can arise directly from HPH. Consequently, MTP and the compounds formed during its further biotransformation may not provide any valid measure of the extent to which H is acetylated in vivo.

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.